The Journal of Personalized and Precision Pharmacology (JPPP) is a peer-reviewed, open-access scholarly journal dedicated to advancing the science and practice of individualized pharmacological care. We provide a dynamic platform for researchers, clinicians, and healthcare innovators to publish high-quality, impactful research that enhances therapeutic strategies tailored to the unique genetic, molecular, and clinical profiles of individual patients.
Our mission is to bridge the gap between bench and bedside by fostering research that translates genetic and biomarker data into actionable clinical insights. JPPP emphasizes the role of pharmacogenomics, precision drug delivery, personalized therapeutics, and biotechnology-driven approaches in revolutionizing modern medicine.
Vision
To become a leading global forum for research and dialogue that drives the development and implementation of personalized pharmacological treatments, improving healthcare outcomes and quality of life across diverse populations.
Our Objectives
- To disseminate cutting-edge research in precision pharmacology and related domains.
- To promote interdisciplinary collaboration among scientists, pharmacologists, and clinicians.
- To support innovations that enable patient-specific treatment decisions.
- To encourage ethical and regulatory discourse in the realm of personalized medicine.
Audience
Our readership includes but is not limited to:
- Clinical and Translational Researchers
- Pharmacologists and Toxicologists
- Pharmaceutical Scientists and Biotechnologists
- Geneticists and Molecular Biologists
- Regulatory Affairs Experts
- Healthcare Professionals and Policy Makers
JPPP is committed to scientific integrity, innovation, and inclusivity, and we continuously strive to highlight research that sets the standard for precision pharmacotherapy worldwide.
